慢性咳嗽の世界市場レポート 2024

慢性咳嗽の市場規模は、今後数年間で大幅な成長が見込まれています。 2028年には8.9%の年間複合成長率（CAGR）で114億8,000万米ドルに成長すると予想されます。予測期間で予想される成長は、特定の経路を標的とした治療法の出現、逆流性咳嗽への理解の深まり、禁煙における世界の取り組み、環境および労働衛生政策の実施に起因すると考えられます。予測期間の主な動向には、診断技術の進歩、患者中心のアプローチの採用、神経性咳嗽の革新的な治療法、慢性咳嗽管理のための遠隔医療の統合、中枢性感作に関する進行中の調査が含まれます。これらの動向は集合的に、慢性咳嗽の管理とケアの進化する情勢に貢献しています。

咳の発生率の急増により、近い将来、慢性咳嗽市場の拡大が促進されると予想されます。咳は、気道から刺激物や異物を排出する自然な反射であり、咳が8週間を超えて続く場合、慢性と呼ばれます。全体的な咳の増加は、慢性咳嗽の増加と直接相関しています。たとえば、Florida Healthの2022年 3月のデータによると、米国では2021年に合計 80件の症例が報告され、咳と百日咳の症例発生率はそれぞれ100,000人あたり41.0と1.4でした。同様に、デンマークのスタテンス血清研究所の調査結果では、2022年11月から2023年4月までの百日咳症例が前年と比較して41%増加したことが明らかになりました。この咳関連症状、特に百日咳の蔓延の拡大は、慢性咳嗽市場の成長の原動力となっています。

喫煙とタバコの使用の普及の増加は、慢性咳嗽市場の拡大に寄与すると予想されます。喫煙は、タバコの煙の吸入または吸収を伴う習慣であり、とりわけ、慢性気管支炎、粘液生成の増加、肺機能の低下、免疫系の低下などの健康問題を引き起こします。米国疾病管理予防センターの2023年 11月の報告書によると、2021年の米国の成人は推定2,830万人で、成人人口の11.5%を占めています。喫煙率とタバコの使用の増加は、長引く咳の問題に大きく寄与しており、市場での慢性咳嗽の治療法や治療法に対する需要が増大しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 マクロ経済シナリオ

• 高インフレが市場に与える影響
• ウクライナ・ロシア戦争が市場に与える影響
• COVID-19による市場への影響

第5章 世界市場規模と成長

• 世界の市場促進要因と抑制要因
  • 市場促進要因
  • 市場抑制要因
• 世界の市場規模実績と成長、2018年～2023年
• 世界の市場規模予測と成長、2023年～2028年、2033年

第6章 市場セグメンテーション

• 世界の慢性咳嗽市場、薬剤クラス別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 抗ヒスタミン薬
• コルチコステロイド
• 鼻詰まり除去剤
• 配合剤
• 抗生物質
• 酸ブロッカー
• その他
• 世界の慢性咳嗽市場、投与経路別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 経口
• 吸入
• 注射
• その他
• 世界の慢性咳嗽市場、流通チャネル別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院薬局
• オンライン薬局
• 小売薬局
• 世界の慢性咳嗽市場、エンドユーザー別セグメンテーション、実績および予測、2018-2023年、2023-2028年、2033年
• 病院
• ホームケア
• 専門センター
• その他

第7章 地域および国の分析

• 世界の慢性咳嗽市場、地域別、実績および予測、2018-2023年、2023-2028年、2033年
• 世界の慢性咳嗽市場、国別、実績および予測、2018-2023、2023-2028年、2033年

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 慢性咳嗽市場の競合情勢
• 慢性咳嗽市場の企業プロファイル
  • Tris Pharma Inc.
  • Pfizer Inc.
  • Johnson &Johnson Co
  • Bayer AG
  • Novartis AG

第31章 その他の大手および革新的な企業

• Sanofi SA
• Bristol-Myers Squibb Company
• AstraZeneca plc
• Glaxo SmithKline Plc
• Merck KGaA
• Reckitt Benckiser Group plc
• Glenmark Pharmaceuticals Ltd
• Teva Pharmaceutical Industries Ltd.
• Mylan NV
• Aurobindo Pharma Ltd.
• Cipla Limited
• Apotex Inc.
• Hikma Pharmaceuticals Plc
• Amneal Pharmaceuticals LLC
• Mount Sinai Health System

第32章 競合ベンチマーキング

第33章 競合ダッシュボード

第34章 主要な合併と買収

第35章 将来の見通しと可能性の分析

第36章 付録

Chronic cough is characterized by persistent coughing lasting eight weeks or more, often indicative of an underlying condition such as asthma, allergies, or respiratory infections.

The primary drug classes for chronic cough include antihistamines, corticosteroids, decongestants, combination drugs, antibiotics, acid blockers, and others. Antihistamines are medications designed to address allergies by counteracting the physiological effects of histamines. These drugs can be administered through various routes, including oral, inhalational, injectable, and others, catering to settings such as hospitals, homecare, specialty centers, and more. Distribution channels for chronic cough medications encompass hospital pharmacies, online pharmacies, and retail pharmacies.

The chronic cough market research report is one of a series of new reports from The Business Research Company that provides chronic cough market statistics, including chronic cough industry global market size, regional shares, competitors with a chronic cough market share, detailed chronic cough market segments, market trends and opportunities, and any further data you may need to thrive in the chronic cough industry. This chronic cough market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The chronic cough market size has grown strongly in recent years. It will grow from $7.5 billion in 2023 to $8.16 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth observed in the historical period can be attributed to various factors, including the prevalence of underlying respiratory conditions, environmental factors such as air pollution, smoking and tobacco use, respiratory infections, as well as allergies and environmental sensitivities. These factors collectively contribute to the occurrence and persistence of chronic cough.

The chronic cough market size is expected to see strong growth in the next few years. It will grow to $11.48 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%. The anticipated growth in the forecast period can be attributed to the emergence of therapies targeting specific pathways, a deepening understanding of reflux-related cough, global initiatives in smoking cessation, and the implementation of environmental and occupational health policies. Key trends in the forecast period include advancements in diagnostic technologies, the adoption of patient-centric approaches, innovative treatments for neurogenic cough, the integration of telehealth for chronic cough management, and ongoing research on central sensitization. These trends collectively contribute to the evolving landscape of chronic cough management and care.

The surge in the prevalence of cough incidents is anticipated to drive the expansion of the chronic cough market in the foreseeable future. Coughing is a natural reflex that expels irritants or foreign substances from the airways, and when it persists for a duration exceeding eight weeks, it is termed as chronic. The increase in overall cough instances directly correlates with the rise in chronic cough cases. For example, as per March 2022 data from Florida Health, the US reported a total of 80 cases in 2021, marking an incidence of 41.0 and 1.4 per 100,000 individuals for cough and pertussis cases, respectively. Similarly, findings from the Statens Serum Institut in Denmark revealed a 41% increase in pertussis cases from November 2022 to April 2023 compared to the previous year. This escalating prevalence of cough-related conditions, notably pertussis, is a driving force behind the chronic cough market's growth.

The growing prevalence of smoking and tobacco usage is expected to contribute to the expansion of the chronic cough market. Smoking, a habit involving the inhalation or absorption of tobacco smoke, leads to chronic bronchitis, increased mucus production, reduced lung function, and a compromised immune system, among other health issues. According to the Centers for Disease Control and Prevention's November 2023 report, an estimated 28.3 million adults in the US were cigarette smokers in 2021, accounting for 11.5% of the adult population. The escalating numbers in smoking prevalence and tobacco use significantly contribute to persistent coughing issues, amplifying the demand for chronic cough remedies and treatments in the market.

Major companies in the chronic cough market are directing their efforts towards innovating products such as cough syrup to solidify their market position. Cough syrups serve to alleviate upper respiratory allergies and common colds, typically containing non-opioid cough suppressants that target the brain's specific cough center to reduce coughing. An illustration of this innovation is seen in Sun Pharmaceutical Industries Limited's September 2021 launch of Chericof 12, a novel cough remedy formulation. This prescription cough syrup utilizes Polistirex technology, ensuring a sustained 12-hour relief. This technology facilitates prolonged medication release, enhancing patient adherence by preventing the need for frequent dosage adjustments. By combining chlorpheniramine maleate and dextromethorphan hydrobromide within the Polistirex technology, the formulation gradually releases medication, effectively alleviating coughs over an extended duration.

Leading enterprises in the chronic cough sector are emphasizing technologically advanced products such as cough detectors to drive market growth. Cough detection entails the identification and categorization of cough sounds using cutting-edge technologies such as artificial intelligence (AI) and machine learning. For instance, in May 2023, Hyfe Inc., a US-based company specializing in acoustic epidemiology with a focus on analyzing health sounds, particularly coughs, introduced a digital therapeutic. This innovative digital therapeutic aims to improve patients' lives by providing comprehensive care for chronic cough sufferers. Leveraging Hyfe's expertise in cough monitoring and its extensive database of over 700 million sounds, this digital therapy offers an end-to-end solution for managing coughs. By integrating speech therapy for cough treatment and suppression alongside breathing exercises accessible via mobile devices, this digital therapeutic addresses the needs of chronic cough patients.

In September 2022, the US-based biopharmaceutical company Pfizer Inc. successfully acquired the ASX-listed digital health startup ResApp Health for $115 million. This strategic acquisition was undertaken by Pfizer to strengthen its product portfolio and extend its footprint in key healthcare technology domains. ResApp is a smartphone application known for analyzing coughing patterns, accurately identifying respiratory conditions such as asthma, pneumonia, bronchiolitis, croup, and chronic obstructive pulmonary disease (COPD). ResApp Health, headquartered in Australia, is a healthcare solutions company that specializes in the management of chronic cough. This acquisition reflects Pfizer's commitment to leveraging innovative digital health solutions for enhanced healthcare offerings.

Major companies operating in the chronic cough market report are Tris Pharma Inc., Pfizer Inc., Johnson & Johnson Co, Bayer AG, Novartis AG, Sanofi SA, Bristol-Myers Squibb Company, AstraZeneca PLC, Glaxo SmithKline PLC, Merck KGaA, Reckitt Benckiser Group PLC, Glenmark Pharmaceuticals Ltd., Teva Pharmaceutical Industries Ltd., Mylan NV, Aurobindo Pharma Ltd., Cipla Limited, Apotex Inc., Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Mount Sinai Health System, Biocon Ltd., BELLUS Health Inc., Trevi Therapeutics Inc., Sun Pharmaceutical Industries Ltd., NeRRe Therapeutics Ltd.

North America was the largest region in the chronic cough market in 2023. The regions covered in the chronic cough market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the chronic cough market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The chronic cough market consists of revenues earned by entities by providing services such as chest X-ray or CT scan services, lung function tests, and sputum culture. The market value includes the value of related goods sold by the service provider or included within the service offering. The chronic cough market also includes sales of cough suppressants, expectorants, inhalers, and allergy medications which are used in providing the services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Chronic Cough Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on chronic cough market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
• Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
• Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
• Measure the impact of high global inflation on market growth.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for chronic cough ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The chronic cough market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

• 1) By Drug Class: Antihistamines; Corticosteroids; Decongestants; Combination Drug; Antibiotics; Acid Blockers; Other Drug Classes
• 2) By Route Of Administration: Oral; Inhalational; Injectable; Other Route of Administrations
• 3) By End-Users: Hospitals; Homecare; Specialty Centers; Other End Users
• 4) By Distribution Channel: Hospital Pharmacy; Online Pharmacy; Retail Pharmacy
• Companies Mentioned: Tris Pharma Inc.; Pfizer Inc.; Johnson & Johnson Co; Bayer AG; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Chronic Cough Market Characteristics

3. Chronic Cough Market Trends And Strategies

4. Chronic Cough Market - Macro Economic Scenario

• 4.1. Impact Of High Inflation On The Market
• 4.2. Ukraine-Russia War Impact On The Market
• 4.3. COVID-19 Impact On The Market

5. Global Chronic Cough Market Size and Growth

• 5.1. Global Chronic Cough Market Drivers and Restraints
  • 5.1.1. Drivers Of The Market
  • 5.1.2. Restraints Of The Market
• 5.2. Global Chronic Cough Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
• 5.3. Global Chronic Cough Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Chronic Cough Market Segmentation

• 6.1. Global Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Antihistamines
• Corticosteroids
• Decongestants
• Combination Drug
• Antibiotics
• Acid Blockers
• Other Drug Classes
• 6.2. Global Chronic Cough Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Oral
• Inhalational
• Injectable
• Other Route of Administrations
• 6.3. Global Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy
• 6.4. Global Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• Hospitals
• Homecare
• Specialty Centers
• Other End Users

7. Chronic Cough Market Regional And Country Analysis

• 7.1. Global Chronic Cough Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 7.2. Global Chronic Cough Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Chronic Cough Market

• 8.1. Asia-Pacific Chronic Cough Market Overview
• Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.3. Asia-Pacific Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 8.4. Asia-Pacific Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Chronic Cough Market

• 9.1. China Chronic Cough Market Overview
• 9.2. China Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.3. China Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
• 9.4. China Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Chronic Cough Market

• 10.1. India Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.2. India Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 10.3. India Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Chronic Cough Market

• 11.1. Japan Chronic Cough Market Overview
• 11.2. Japan Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.3. Japan Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 11.4. Japan Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Chronic Cough Market

• 12.1. Australia Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.2. Australia Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 12.3. Australia Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Chronic Cough Market

• 13.1. Indonesia Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.2. Indonesia Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 13.3. Indonesia Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Chronic Cough Market

• 14.1. South Korea Chronic Cough Market Overview
• 14.2. South Korea Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.3. South Korea Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 14.4. South Korea Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Chronic Cough Market

• 15.1. Western Europe Chronic Cough Market Overview
• 15.2. Western Europe Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.3. Western Europe Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 15.4. Western Europe Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Chronic Cough Market

• 16.1. UK Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.2. UK Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 16.3. UK Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Chronic Cough Market

• 17.1. Germany Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.2. Germany Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 17.3. Germany Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Chronic Cough Market

• 18.1. France Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.2. France Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 18.3. France Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Chronic Cough Market

• 19.1. Italy Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.2. Italy Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 19.3. Italy Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Chronic Cough Market

• 20.1. Spain Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.2. Spain Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 20.3. Spain Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Chronic Cough Market

• 21.1. Eastern Europe Chronic Cough Market Overview
• 21.2. Eastern Europe Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.3. Eastern Europe Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 21.4. Eastern Europe Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Chronic Cough Market

• 22.1. Russia Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.2. Russia Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 22.3. Russia Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Chronic Cough Market

• 23.1. North America Chronic Cough Market Overview
• 23.2. North America Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.3. North America Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 23.4. North America Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Chronic Cough Market

• 24.1. USA Chronic Cough Market Overview
• 24.2. USA Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.3. USA Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 24.4. USA Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Chronic Cough Market

• 25.1. Canada Chronic Cough Market Overview
• 25.2. Canada Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.3. Canada Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 25.4. Canada Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Chronic Cough Market

• 26.1. South America Chronic Cough Market Overview
• 26.2. South America Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.3. South America Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 26.4. South America Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Chronic Cough Market

• 27.1. Brazil Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.2. Brazil Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 27.3. Brazil Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Chronic Cough Market

• 28.1. Middle East Chronic Cough Market Overview
• 28.2. Middle East Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.3. Middle East Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 28.4. Middle East Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Chronic Cough Market

• 29.1. Africa Chronic Cough Market Overview
• 29.2. Africa Chronic Cough Market, Segmentation By Drug Class, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.3. Africa Chronic Cough Market, Segmentation By Distribution Channel, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
• 29.4. Africa Chronic Cough Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Chronic Cough Market Competitive Landscape And Company Profiles

• 30.1. Chronic Cough Market Competitive Landscape
• 30.2. Chronic Cough Market Company Profiles
  • 30.2.1. Tris Pharma Inc.
    • 30.2.1.1. Overview
    • 30.2.1.2. Products and Services
    • 30.2.1.3. Strategy
    • 30.2.1.4. Financial Performance
  • 30.2.2. Pfizer Inc.
    • 30.2.2.1. Overview
    • 30.2.2.2. Products and Services
    • 30.2.2.3. Strategy
    • 30.2.2.4. Financial Performance
  • 30.2.3. Johnson & Johnson Co
    • 30.2.3.1. Overview
    • 30.2.3.2. Products and Services
    • 30.2.3.3. Strategy
    • 30.2.3.4. Financial Performance
  • 30.2.4. Bayer AG
    • 30.2.4.1. Overview
    • 30.2.4.2. Products and Services
    • 30.2.4.3. Strategy
    • 30.2.4.4. Financial Performance
  • 30.2.5. Novartis AG
    • 30.2.5.1. Overview
    • 30.2.5.2. Products and Services
    • 30.2.5.3. Strategy
    • 30.2.5.4. Financial Performance

31. Chronic Cough Market Other Major And Innovative Companies

• 31.1. Sanofi SA
• 31.2. Bristol-Myers Squibb Company
• 31.3. AstraZeneca plc
• 31.4. Glaxo SmithKline Plc
• 31.5. Merck KGaA
• 31.6. Reckitt Benckiser Group plc
• 31.7. Glenmark Pharmaceuticals Ltd
• 31.8. Teva Pharmaceutical Industries Ltd.
• 31.9. Mylan NV
• 31.10. Aurobindo Pharma Ltd.
• 31.11. Cipla Limited
• 31.12. Apotex Inc.
• 31.13. Hikma Pharmaceuticals Plc
• 31.14. Amneal Pharmaceuticals LLC
• 31.15. Mount Sinai Health System

32. Global Chronic Cough Market Competitive Benchmarking

33. Global Chronic Cough Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Chronic Cough Market

35. Chronic Cough Market Future Outlook and Potential Analysis

• 35.1 Chronic Cough Market In 2028 - Countries Offering Most New Opportunities
• 35.2 Chronic Cough Market In 2028 - Segments Offering Most New Opportunities
• 35.3 Chronic Cough Market In 2028 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer